Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitus, from French biotechnology company AMMTeK.

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.

Roche has signed an agreement to acquire Poseida Therapeutics in a $1.5bn deal. The transaction includes Poseida's clinical ...

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology ...

China’s NMPA has approved MSD’s WELIREG (belzutifan) to treat adult individuals with certain types of VHL disease-associated ...

The US Food and Drug Administration (FDA) has approved BridgeBio Pharma ’s Attruby (acoramidis), an oral transthyretin (TTR) ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

Since 2023, the pharmaceutical industry operating in Europe has faced an unprecedented challenge related to drug shortages.